Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT00049374 · COMPLETED
Trial details
- NCT number
- NCT00049374
- Sponsor
- University of Maryland, Baltimore
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Primary completion
- 2006-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.